| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
ILAE official report: a practical clinical definition of epilepsy.
|
Epilepsia
|
2014
|
7.12
|
|
2
|
Standards for epidemiologic studies and surveillance of epilepsy.
|
Epilepsia
|
2011
|
3.48
|
|
3
|
Incidence and mechanisms of cardiorespiratory arrests in epilepsy monitoring units (MORTEMUS): a retrospective study.
|
Lancet Neurol
|
2013
|
3.06
|
|
4
|
Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies.
|
Epilepsia
|
2008
|
2.74
|
|
5
|
Unifying the definitions of sudden unexpected death in epilepsy.
|
Epilepsia
|
2011
|
2.24
|
|
6
|
Mortality of epilepsy in developed countries: a review.
|
Epilepsia
|
2005
|
1.44
|
|
7
|
Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X).
|
Epilepsy Res
|
2010
|
1.35
|
|
8
|
Hospitalization for psychiatric disorders before and after onset of unprovoked seizures/epilepsy.
|
Neurology
|
2012
|
1.32
|
|
9
|
Risk factors for suicide in epilepsy: a case control study.
|
Epilepsia
|
2002
|
1.29
|
|
10
|
Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI).
|
Epilepsy Res
|
2012
|
1.24
|
|
11
|
Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII).
|
Epilepsy Res
|
2006
|
1.23
|
|
12
|
The pharmacological treatment of epilepsy in adults.
|
Lancet Neurol
|
2011
|
1.22
|
|
13
|
Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX).
|
Epilepsy Res
|
2008
|
1.20
|
|
14
|
Oral contraceptives reduce lamotrigine plasma levels.
|
Neurology
|
2003
|
1.18
|
|
15
|
Therapeutic drug monitoring of the newer antiepileptic drugs.
|
Ther Drug Monit
|
2003
|
1.15
|
|
16
|
Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
|
Clin Pharmacokinet
|
2006
|
1.14
|
|
17
|
EURAP: an international registry of antiepileptic drugs and pregnancy.
|
Epilepsia
|
2004
|
1.07
|
|
18
|
Seizure control and treatment changes in pregnancy: observations from the EURAP epilepsy pregnancy registry.
|
Epilepsia
|
2013
|
1.07
|
|
19
|
Effects of the antiepileptic drugs lamotrigine, topiramate and gabapentin on hERG potassium currents.
|
Epilepsy Res
|
2004
|
1.07
|
|
20
|
Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy.
|
Epilepsia
|
2007
|
1.06
|
|
21
|
Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII).
|
Epilepsy Res
|
2004
|
1.05
|
|
22
|
Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations.
|
Epilepsia
|
2002
|
1.05
|
|
23
|
Comment on epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE).
|
Epilepsia
|
2005
|
1.03
|
|
24
|
Host factors affecting antiepileptic drug delivery-pharmacokinetic variability.
|
Adv Drug Deliv Rev
|
2011
|
0.98
|
|
25
|
Management of epilepsy during pregnancy.
|
Drugs
|
2007
|
0.97
|
|
26
|
Prevention of sudden unexpected death in epilepsy: a realistic goal?
|
Epilepsia
|
2013
|
0.96
|
|
27
|
Managing antiepileptic drugs during pregnancy and lactation.
|
Curr Opin Neurol
|
2009
|
0.96
|
|
28
|
Phenytoin and phenobarbital inhibit human HERG potassium channels.
|
Epilepsy Res
|
2003
|
0.96
|
|
29
|
Pharmacokinetics of gabapentin during delivery, in the neonatal period, and lactation: does a fetal accumulation occur during pregnancy?
|
Epilepsia
|
2005
|
0.91
|
|
30
|
Effects of pregnancy and contraception on lamotrigine disposition: new insights through analysis of lamotrigine metabolites.
|
Seizure
|
2008
|
0.88
|
|
31
|
Serum concentrations and effects of gabapentin and vigabatrin: observations from a dose titration study.
|
Ther Drug Monit
|
2003
|
0.87
|
|
32
|
Carbamazepine affects autonomic cardiac control in patients with newly diagnosed epilepsy.
|
Epilepsy Res
|
2003
|
0.86
|
|
33
|
Debate: Substitution of generic drugs in epilepsy: is there cause for concern?
|
Epilepsia
|
2008
|
0.86
|
|
34
|
Hyponatremia and risk of seizures: a retrospective cross-sectional study.
|
Epilepsia
|
2011
|
0.85
|
|
35
|
Increased risk and worse prognosis of myocardial infarction in patients with prior hospitalization for epilepsy--the Stockholm Heart Epidemiology Program.
|
Brain
|
2009
|
0.84
|
|
36
|
The treatment gap of epilepsy in a rural district of Vietnam: a study from the EPIBAVI project.
|
Epilepsia
|
2009
|
0.84
|
|
37
|
[It's possible to influence prescriptions patterns by producer-independent information].
|
Lakartidningen
|
2004
|
0.84
|
|
38
|
Newly diagnosed single unprovoked seizures and epilepsy in Stockholm, Sweden: First report from the Stockholm Incidence Registry of Epilepsy (SIRE).
|
Epilepsia
|
2008
|
0.84
|
|
39
|
The prevalence of epilepsy in a rural district of Vietnam: a population-based study from the EPIBAVI project.
|
Epilepsia
|
2008
|
0.83
|
|
40
|
The management of epilepsy during pregnancy--progress is painfully slow.
|
Epilepsia
|
2009
|
0.80
|
|
41
|
Pharmacokinetics of topiramate during pregnancy.
|
Epilepsy Res
|
2009
|
0.80
|
|
42
|
Circadian variation in heart-rate variability in localization-related epilepsy.
|
Epilepsia
|
2007
|
0.79
|
|
43
|
Unprovoked seizures in multiple sclerosis and systemic lupus erythematosus: a population-based case-control study.
|
Epilepsy Res
|
2012
|
0.79
|
|
44
|
Which drug for the pregnant woman with epilepsy?
|
N Engl J Med
|
2009
|
0.79
|
|
45
|
Prior hospitalization for stroke, diabetes, myocardial infarction, and subsequent risk of unprovoked seizures.
|
Epilepsia
|
2010
|
0.78
|
|
46
|
What is important in rehabilitation for persons with epilepsy? Experiences from focus group interviews with patients and staff.
|
Epilepsy Behav
|
2013
|
0.78
|
|
47
|
Adjunctive antiepileptic drug therapy and prevention of SUDEP.
|
Lancet Neurol
|
2011
|
0.78
|
|
48
|
Old versus new antiepileptic drugs: the SANAD study.
|
Lancet
|
2007
|
0.77
|
|
49
|
Association between sociodemographic status and antiepileptic drug prescriptions in children with epilepsy.
|
Epilepsia
|
2012
|
0.77
|
|
50
|
Optimizing treatment of epilepsy during pregnancy.
|
Neurology
|
2006
|
0.77
|
|
51
|
Microdialysis sampling of carbamazepine, phenytoin and phenobarbital in subcutaneous extracellular fluid and subdural cerebrospinal fluid in humans: an in vitro and in vivo study of adsorption to the sampling device.
|
Pharmacol Toxicol
|
2002
|
0.76
|
|
52
|
Lamotrigine and the risk of malformations in pregnancy.
|
Neurology
|
2006
|
0.75
|
|
53
|
Commentary: Valproate in the treatment of epilepsy in women and girls: The need for recommendations.
|
Epilepsia
|
2015
|
0.75
|
|
54
|
Major birth defects after exposure to newer-generation antiepileptic drugs.
|
JAMA
|
2011
|
0.75
|
|
55
|
Excess mortality in epilepsy in developing countries.
|
Lancet Neurol
|
2006
|
0.75
|
|
56
|
Genetic screening for SUDEP?--Commentary on Hindocha et al.
|
Epilepsia
|
2008
|
0.75
|
|
57
|
[Antiepileptic treatment nearly six times more expensive since 1990].
|
Lakartidningen
|
2003
|
0.75
|
|
58
|
The incidence of epilepsy in a rural district of Vietnam: a community-based epidemiologic study.
|
Epilepsia
|
2010
|
0.75
|
|
59
|
The remarkable story of valproic acid.
|
Lancet Neurol
|
2016
|
0.75
|
|
60
|
Intracranial meningiomas and seizures: a review of the literature.
|
Acta Neurochir (Wien)
|
2015
|
0.75
|
|
61
|
Epilepsy and menopause: potential implications for pharmacotherapy.
|
Drugs Aging
|
2014
|
0.75
|
|
62
|
[Complicated drug interactions].
|
Lakartidningen
|
2003
|
0.75
|
|
63
|
Epilepsy: seizures, syndromes, and survival.
|
Lancet Neurol
|
2009
|
0.75
|
|
64
|
Unbound valproate fraction in plasma and subcutaneous microdialysate in steady state and after a single dose in humans.
|
Ther Drug Monit
|
2003
|
0.75
|
|
65
|
Long-term follow-up after comprehensive rehabilitation of persons with epilepsy, with emphasis on participation in employment or education.
|
Epilepsy Behav
|
2012
|
0.75
|